Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
228
NCT03047629
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 11, 2017
Completion: Jun 14, 2018
NCT03781791
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Phase: Phase 2
Start: Dec 10, 2018
Completion: Dec 14, 2021
NCT04483479
"Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety Roll-over Study (Rollover)"
Start: Jul 30, 2020
Completion: Feb 17, 2022
NCT03938922
A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia
Phase: Phase 1
Start: Mar 1, 2024
Completion: Dec 15, 2025